Walworth Nathan G, Lee Michael D, Suffridge Christopher, Qu Pingping, Fu Fei-Xue, Saito Mak A, Webb Eric A, Sañudo-Wilhelmy Sergio A, Hutchins David A
Department of Biological Sciences, University of Southern California, Los Angeles, CA, United States.
Marine Chemistry and Geochemistry Department, Woods Hole Oceanographic Institution, Woods Hole, MA, United States.
Front Microbiol. 2018 Feb 13;9:189. doi: 10.3389/fmicb.2018.00189. eCollection 2018.
Only select prokaryotes can biosynthesize vitamin B (i.e., cobalamins), but these organic co-enzymes are required by all microbial life and can be vanishingly scarce across extensive ocean biomes. Although global ocean genome data suggest cyanobacteria to be a major euphotic source of cobalamins, recent studies have highlighted that >95% of cyanobacteria can only produce a cobalamin analog, pseudo-B, due to the absence of the BluB protein that synthesizes the α ligand 5,6-dimethylbenzimidizole (DMB) required to biosynthesize cobalamins. Pseudo-B is substantially less bioavailable to eukaryotic algae, as only certain taxa can intracellularly remodel it to one of the cobalamins. Here we present phylogenetic, metagenomic, transcriptomic, proteomic, and chemical analyses providing multiple lines of evidence that the nitrogen-fixing cyanobacterium transcribes and translates the biosynthetic, cobalamin-requiring BluB enzyme. Phylogenetic evidence suggests that the DMB biosynthesis gene, , is of ancient origin, which could have aided in its ecological differentiation from other nitrogen-fixing cyanobacteria. Additionally, orthologue analyses reveal two genes encoding iron-dependent B biosynthetic enzymes (cbiX and isiB), suggesting that iron availability may be linked not only to new nitrogen supplies from nitrogen fixation, but also to B inputs by . These analyses suggest that contains the genus-wide genomic potential for a previously unrecognized role as a source of cobalamins, which may prove to considerably impact marine biogeochemical cycles.
只有特定的原核生物能够生物合成维生素B(即钴胺素),但所有微生物生命都需要这些有机辅酶,而在广阔的海洋生物群落中,它们可能极其稀少。尽管全球海洋基因组数据表明蓝细菌是钴胺素的主要真光层来源,但最近的研究强调,由于缺乏合成钴胺素所需的α配体5,6-二甲基苯并咪唑(DMB)的BluB蛋白,超过95%的蓝细菌只能产生一种钴胺素类似物,即假维生素B。假维生素B对真核藻类的生物可利用性要低得多,因为只有某些分类群能够在细胞内将其重塑为一种钴胺素。在这里,我们展示了系统发育、宏基因组、转录组、蛋白质组和化学分析,提供了多方面的证据,表明固氮蓝细菌转录并翻译了生物合成所需钴胺素的BluB酶。系统发育证据表明,DMB生物合成基因起源古老,这可能有助于其与其他固氮蓝细菌在生态上的分化。此外,直系同源物分析揭示了两个编码铁依赖性维生素B生物合成酶的基因(cbiX和isiB),这表明铁的可利用性可能不仅与固氮产生的新氮供应有关,还与该蓝细菌的维生素B输入有关。这些分析表明,该蓝细菌具有全属范围的基因组潜力,可发挥此前未被认识到的作为钴胺素来源的作用,这可能对海洋生物地球化学循环产生重大影响。